EDWARDS INTUITY Valve System CADENCE Study

NCT ID: NCT02688153

Last Updated: 2018-06-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2016-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study purpose is to compare the EDWARDS INTUITY valve system with commercially available stented aortic bioprostheses, in patients requiring aortic valve replacement surgery with coronary artery bypass.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized study comparing the cross-clamp time (XCT) and cardiopulmonary bypass time (CPBT) of the EDWARDS INTUITY valve system with any commercially available stented aortic bioprosthesis, in patients with logistic EuroSCORE 1 ≥ 6 undergoing elective surgical aortic valve replacement surgery with concomitant coronary bypass grafts.

Additionally, the aim is to gather sufficient data to quantify the effect size of short term patient benefit outcomes previously identified from literature and finally to explore additional healthcare resource utilization or health economic endpoints.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Disease Aortic Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EDWARDS INTUITY

EDWARDS INTUITY Valve System, Model 8300A

Group Type ACTIVE_COMPARATOR

EDWARDS INTUITY

Intervention Type DEVICE

To evaluate cardiac performance characteristics and adverse events rates associated with the EDWARDS INTUITY Valve in patients undergoing AVR \& CABG.

Stented aortic bioprostheses

Stented aortic bioprostheses

Group Type ACTIVE_COMPARATOR

Stented aortic bioprostheses

Intervention Type DEVICE

In comparison to control valves available on the market.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EDWARDS INTUITY

To evaluate cardiac performance characteristics and adverse events rates associated with the EDWARDS INTUITY Valve in patients undergoing AVR \& CABG.

Intervention Type DEVICE

Stented aortic bioprostheses

In comparison to control valves available on the market.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

aortic stenosis stenosis-based insufficiency aortic valve replacement aortic stenosis stenosis-based insufficiency aortic valve replacement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥18 years of age
* aortic stenosis / mixed aortic stenosis and aortic insufficiency
* SAVR+CABG (1-4 distal anastomoses)
* Log. EuroSCORE ≥6
* NYHA Class ≥II

Exclusion (i.a.):

* pure aortic insufficiency
* pre-existing prosthetic heart valve or ring
* congenital true bicuspid / unicuspid aortic valve
* LVEF \<20%
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Edwards Lifesciences

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Prof. Labrousse, MD

Role: PRINCIPAL_INVESTIGATOR

CHU Bordeaux - Hôpital Haut-Lévèque

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Bordeaux, Hôpital Haut-Lévêque

Pessac, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.